Advertise on podcast: Eyeluminaries

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Bill Carpou, CEO of Octane, to discuss his transition to executive chairman of the organization. ·       Tell us about your background. 2:24 ·       How has Octane changed under your leadership? What does the future hold? 4:01 ·       What does Octane do? 8:57 ·       What will be different, and what will remain the same? 12:07 ·       What are the differences between ophthalmology/optometry and other specialties? 15:20 ·       What trends are you seeing in eye care? 18:08 ·       What is causing the slowdown of cataract procedures? 20:21 We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn. To find out more about Octane, click here. Disclosures: Carpou reports being CEO of Octane. Hovanesian reports consulting widely in the ophthalmic field and being a strategic medical advisor for Tenpoint Therapeutics. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Lab, Bain Capital, CVC Capital Partners and Zeiss; being executive chairman of Neurotech, Preceyes BV and TearLab; and sitting on the board of Centricity Vision, Crystilex, LensGen and Visus.

In this last episode from ASCRS 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Perry J. Sternberg of Sydnexis, Nancy Beesley, and Jean-Pierre Hubschman, MD, of Horizon Surgical Systems, to discuss myopia in children, cataract surgery assisted by AI and robotics, and more. ·       Welcome Perry J. Sternberg and Nancy Beesley. 0:44 ·       How and why is SYD-101 different from atropine? 3:20 ·       What happened with the FDA approval? 8:24 ·       Tell us about the study. 10:57 ·       Welcome Jean-Pierre Hubschman, MD. 20:32 ·       Transitioning from retina to cataracts. 21:02 ·       How do you address concerns about AI replacing surgeons? 24:19 ·       Transitioning from physician to CEO. 28:46 We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Warren Foust, the newest CEO and president of STAAR Surgical. They discuss changing careers, what it's like to find yourself in a leadership position and more. ·       Introducing Warren Foust 0:44 ·       What advice would you give others about becoming a leader in ophthalmology? 7:13 ·       What did you learn throughout this process of change? 10:00 ·       What plans do you have for the future? 12:46 ·       How do you define innovation? 14:52 We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode, live from SightLine 2026, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down with Ben Bergo and Carol Kearney of Tenpoint Therapeutics. They discuss the approval of Yuvezzi (carbachol 2.75% and brimonidine tartrate 0.1% ophthalmic solution) for presbyopia as well as what it takes to launch a new product in a competitive market. ·       The beginning of Yuvezzi. 2:11 ·       How do you differentiate yourself from other products in the market? 7:34 ·       The fear of retinal detachment. 10:55 ·       Advice for young entrepreneurs. 13:31 ·       The decision to use brimonidine tartrate. 16:37 We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS, @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In the last episode from this year's Live from Hawaiian Eye series, Jim Mazzo and John A. Hovanesian, MD, FACS, sit down together to discuss the podcast's annual drug name awards. ·       Vizz or the Mazzo "rizz." 02:37 ·       Qlosi gets the "cutesy" award. 04:01 ·       Tryptyr. 05:35 ·       Encelto. 06:57 We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this special edition episode of Eyeluminaries, Jim Mazzo is live from Hawaiian Eye 2026 with special guest Cathleen McCabe, MD, host of Healio's Mend the Gap. They discuss what shaped their careers and how to be good mentors. ·        Cathleen McCabe, MD  01:17 ·        An important career shift. 01:48 ·        "Grab every minute you can." 11:01 ·        Mentors and mentees. 13:55 Be sure to listen to the second of this conversation on Mend the Gap. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn. For more from Cathleen McCabe, MD, follow her @CathyEye on Instagram and on X.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026 with guests Elizabeth Yeu, MD, and Allen C. Ho, MD. They discuss cataract and retina surgery, managing work-life balance and more. ·        Welcome to Eyeluminaries. 00:01 ·        Elizabeth Yeu, MD, 00:11 ·        How do you see Implantable Collamer Lens (ICL, STAAR Surgical) surgery expanding? 01:23 ·        How long have you been with Tarsus Pharmaceuticals? 05:00 ·        How do you have work-life balance? 08:21 ·        Allen C. Ho, MD 11:38 ·        What got you into retina? 12:55 ·        How has the evolution of retina surgery changed your practice? 14:55 ·        Tell us about your role at Eyecelerator. 17:00 ·        How do you manage your work-life balance? 18:39 ·        Thank you! 20:19 Elizabeth Yeu, MD, is an ophthalmologist and cornea and cataract surgeon. She is the chief medical officer of Tarsus Pharmaceuticals as well as past president of the American Society of Cataract and Refractive Surgery. Allen C. Ho, MD, is a retina surgeon at Wills Eye Hospital, past president of the Retina Society and Eyecelerator retina program chair. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John A. Hovanesian, MD, FACS @DrHovanesian on Instagram and X and John Hovanesian on LinkedIn.

In this episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guests Baruch D. Kuppermann, MD, PhD and L. Jay Katz, MD. They discuss everything from their unique career journeys to the current treatments and procedures in eye care. Welcome to Eyeluminaries 00:10 Recap of AAO episode 00:34 Intro of Baruch D. Kuppermann, MD, PhD 01:28 What made you enter retina and how has your career evolved? 03:02 The Gavin Herbert Eye Institute 06:02 What are your other interests? 12:09 Nonprofit work and the Armenian EyeCare Project 13:07 Intro of L. Jay Katz, MD 17:14 How did you get into glaucoma? 18:03 How are things going to evolve in treatment and procedures? 20:28 What was the driving force behind leaving academia and working with Glaukos? 25:01 Tell us a favorite Tom Burns story! 26:44 Thank you! 29:50 Baruch D. Kuppermann, MD, PhD, is the Roger F. Steinert Professor, Chair of the Department of Ophthalmology, and Director of the Gavin Herbert Eye Institute at the University of California, Irvine. L. Jay Katz, MD, is the chief medical officer at Glaukos. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.

In this special episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guest Peter N. Slack, president and CEO of the Wyanoke Group, who was honored with the annual Lindstrom Leadership Award and Lecture . Welcome to Eyeluminaries 00:42 Hawaiian Eye 2026 – Peter Slack receives the Lindstrom Leadership Award 01:08 Intro of Peter Slack 02:42 What is the history of OSN and your involvement of the company?  04:09 The philosophy of the editorial board 06:41 Lindstrom Leadership Award/ Longevity of employees 08:43 Healio meetings and lifelong friends 10:58 Healio meetings and golf 12:40 Sunshine Eye 14:18 Thank you, Peter Slack and congratulations! 16:29 Check out Healio AI 17:02 Thank you! 18:00 Peter N. Slack, is the president and CEO of the Wyanoke Group. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.

In the second installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guest Thomas Burns. Welcome to the Eyeluminaries podcast 00:01 Quick recap of Part 1 00:08 Intro of Thomas Burns 00:30 How do we foresee the adoption of IDose?  02:02 Where do you see the field of keratoconus going? 04:36 What advice do you have for young people just starting out? 08:36 Who is a mentor for you? 11:06 Do you have a good Jim Mazzo story? 15:38 Thank you, Tom Burns 16:44 Thank you! 17:11 Thomas Burns is the chairman and CEO of Glaukos. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X @DrHovanesian.

In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit "Sam" Garg, MD and Jean-Pierre Hubschman, MD. Welcome to the Eyeluminaries podcast 00:05 Review of episode 33 00:49 Intro of Tibor Juhasz, PhD 01:35 Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27 How is ViaLase impacting glaucoma treatment? 06:55 How the treatment works 08:24 The importance of having a good team 11:02 Intro of Richard L. Lindstrom, MD 12:58 What is your perspective on what is happening today and what changes are you hoping for? 14:28 Integrated eye care delivery 17:00 Dentistry, a future model for eye care 17:50 Post-graduate medical education is changing 19:09 Was there a technology that you thought was a slam dunk and failed? 23:01 Any technology that you didn't expect to take off? 24:37 Intro of Sumit "Sam" Garg, MD 26:58 What do you see changing in ophthalmology residency programs around the country? 28:52 How do you instruct young physicians to be collaborative in care? 30:42 If you weren't a cornea specialist (or a model) what would you be? 32:10 Advice for young ophthalmologists today? 33:42 Share a Jim Mazzo story with us! 35:28 Intro of Jean-Pierre Hubschman, MD 37:07 Why did you, with a robotics company, decide to start in cataract surgery? 38:23 How do you become more efficient in robotic surgery? 41:00 How do we work on the economic side of this? 43:38 What's it like running a company vs being a retina surgeon? 44:46 Give us your feedback 48:16 Thanks for listening 48:30   Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS. Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News. Sumit "Sam" Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine. Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems.   We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.

In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you're most excited about? 5:10  What challenges do you see in running your practice that didn't exist in your dad's day? 8:36 You've got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09 Besides your dad and the two of us, who do you look up to in eye care? 14:45 Singh sings a Funkadesi song 18:16 Intro of Candy Simerson 20:36 When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41 What about the finances? What areas in finances do you see where improvement can be made? 24:27 In your many years in ophthalmology, what are the biggest challenges you've experienced? 26:10 What type of practice should consider a sale to private equity? What type of practice should not? 29:34 What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29 Intro of the Goldbergs 36:25 Jeff Goldberg, MD, PhD 36:50 Roger Goldberg, MD, MBA 37:21 Jeff, why glaucoma instead of retina? 38:43 Roger, why retina instead of glaucoma? 39:37 Mazzo discusses neuroprotection in retina and glaucoma. 41:14 What is entrepreneurship like today? What's your advice? What is challenging and what is positive? 43:10 Mazzo discusses being realistic about innovations. 48:30 What is private practice like today? 49:31 How do cornea specialists better understand glaucoma specialists? 53:05 How do cornea specialists better understand retina specialists? 54:13 Tell us about emmecell. 55:50 Preview of episode 32 59:19 Give us your feedback 1:00:18 Thanks 1:00:30 Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners. I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message "one family, many children." We'd love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.